Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2022-06-23 Director's Dealing
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 100% confidence The document is a company announcement regarding transactions in shares by managerial employees and their closely associated persons. It explicitly references Article 19 of Regulation No. 596/2014 (Market Abuse Regulation), which governs the disclosure of insider/director dealings. The document serves as an announcement of these transactions and includes an attachment containing the specific trade details. This aligns perfectly with the definition of 'Director's Dealing' (DIRS).
2022-06-23 English
6-K
Foreign Filer Report
2022-06-21 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "Major Shareholder Announcement" and details changes in the shareholding percentage of Wellington Management Group LLP, specifically noting when their holding crossed or moved around the 5% threshold, referencing the Danish Capital Markets Act. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing defined thresholds.
2022-06-20 English
Major Shareholder Announcement
Major Shareholding Notification Classification · 100% confidence The document is titled 'Major Shareholder Announcement' and explicitly details changes in shareholding percentages by Wellington Management Group LLP in Genmab A/S. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2022-06-20 English
6-K
Foreign Filer Report
2022-06-17 English
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 100% confidence The document is titled "Genmab Announces Initiation of Share Buy-Back Program" and details the plan to repurchase up to 370,000 shares to mitigate dilution. This action—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The document is a formal announcement detailing the terms, timeframe, and purpose of the share repurchase program. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2022-06-17 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.